This company listing is no longer active
Central China New Life Future Growth
Future criteria checks 1/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Central China New Life.
Key information
5.3%
Earnings growth rate
5.3%
EPS growth rate
Real Estate earnings growth | 20.8% |
Revenue growth rate | 3.3% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 23 Aug 2023 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2025 | 4,050 | 732 | 381 | 974 | 3 |
12/31/2024 | 3,602 | 609 | 373 | 588 | 3 |
12/31/2023 | 3,214 | 47 | 17 | 601 | 3 |
12/31/2022 | 3,148 | 562 | 296 | 309 | N/A |
9/30/2022 | 3,374 | 606 | 687 | 82 | N/A |
6/30/2022 | 3,600 | 649 | -184 | -145 | N/A |
3/31/2022 | 3,600 | 634 | -19 | 17 | N/A |
12/31/2021 | 3,599 | 620 | 1,408 | 178 | N/A |
9/30/2021 | 3,378 | 561 | 970 | 369 | N/A |
6/30/2021 | 3,157 | 503 | 532 | 560 | N/A |
3/31/2021 | 2,906 | 465 | 395 | 421 | N/A |
12/31/2020 | 2,654 | 427 | 257 | 281 | N/A |
9/30/2020 | 2,395 | 368 | 244 | 263 | N/A |
6/30/2020 | 2,136 | 310 | 231 | 245 | N/A |
3/31/2020 | 1,945 | 274 | 248 | 263 | N/A |
12/31/2019 | 1,754 | 239 | 266 | 281 | N/A |
12/31/2018 | 694 | 89 | 129 | 133 | N/A |
12/31/2017 | 461 | 66 | 80 | 84 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 9983's forecast earnings growth (5.3% per year) is above the savings rate (1.9%).
Earnings vs Market: 9983's earnings (5.3% per year) are forecast to grow slower than the Hong Kong market (15.2% per year).
High Growth Earnings: 9983's earnings are forecast to grow, but not significantly.
Revenue vs Market: 9983's revenue (3.3% per year) is forecast to grow slower than the Hong Kong market (8.7% per year).
High Growth Revenue: 9983's revenue (3.3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 9983's Return on Equity is forecast to be high in 3 years time